ORGANOGENESIS HOLDINGS INC. Severance Costs
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Severance Costs of $1.82 million for the 3-month period ending 2023-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2025-02-27
- ORGANOGENESIS HOLDINGS INC. severance costs for the quarter ending 2023-12-31 was $1.82M.
- ORGANOGENESIS HOLDINGS INC. severance costs for the quarter ending 2023-09-30 was $0.00.
- ORGANOGENESIS HOLDINGS INC. severance costs for the quarter ending 2023-06-30 was -$208.00K.
- ORGANOGENESIS HOLDINGS INC. severance costs for the quarter ending 2023-03-31 was $1.82M.
| Period end | Severance Costs | Severance Costs as first filed | Severance Costs 3 month | Severance Costs 6 month | Severance Costs 9 month | Severance Costs 12 month |
|---|---|---|---|---|---|---|
| 2023-12-31 | $1.82M 10-K · filed 2025-02-27 | $1.82M derived: sum of 2 quarters · filed 2025-02-27 | $1.61M derived: sum of 3 quarters · filed 2025-02-27 | $3.43M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$208.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.61M 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | -$208.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.61M 10-Q · filed 2024-08-08 | ||||
| 2023-03-31 | $1.82M 10-Q · filed 2024-05-09 | |||||
| 2023-02-03 | $1.61M 10-K · filed 2025-02-27 | $1.82M 10-Q · filed 2023-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |